Blood Urea Nitrogen/Creatinine Ratio in Cushing’s Syndrome: Associations With Disease Status and Postoperative Changes
International Journal of Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/ije/2517065 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 12.06.2026. Verfasst von C Yarkutay Turkkan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey, sislietfal.gov.tr. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Although various tests are used for Cushing’s syndrome (CS) screening and diagnosis, none exhibit ideal sensitivity or specificity. This study evaluates the association of the blood urea nitrogen (BUN)/creatinine ratio with disease status in CS and subclinical Cushing’s syndrome (SCS), and with postoperative changes in patients with CS.
Design
A single‐center, observational, cross‐sectional study conducted at Endocrinology and Metabolic Diseases Clinic of a tertiary training and research hospital in Istanbul, Turkey (2017–2022). Patients This study included 229 individuals: 151 CS/SCS patients and 78 healthy controls. CS cases were classified as adrenocorticotropic hormone (ACTH)–dependent ( n = 52) or ACTH‐independent ( n = 34).
Measurements
BUN/creatinine ratios were compared among CS, SCS, and control groups, as well as between pre‐ and posttreatment states in CS patients. Correlations between BUN/creatinine ratio and standard CS diagnostic tests were analyzed. Receiver operating characteristic (ROC) analysis was performed to evaluate the discriminatory performance of the BUN/creatinine ratio between CS and control groups.
Results
BUN/creatinine ratios were significantly higher in CS, ACTH‐independent CS, and SCS groups compared to controls. Cutoff values were > 15.34 for CS, > 13.67 for ACTH‐independent CS, and > 19.8 for SCS. The BUN/creatinine ratio correlated positively with basal plasma cortisol, 1 mg dexamethasone suppression test (DST), and midnight serum cortisol in ACTH‐dependent CS ( p = 0.047, 0.038, 0.004). In all CS patients, it correlated with 1‐mg DST and midnight serum cortisol ( p = 0.041, 0.049). In ACTH‐dependent CS, a positive correlation was found between pituitary adenoma diameter and the preoperative BUN/creatinine ratio ( p = 0.036).
Conclusions
The BUN/creatinine ratio may provide supportive information associated with CS status and postoperative changes in patients with CS, particularly when standard tests are unavailable or inconclusive. Larger multicenter studies are needed to confirm its clinical utility.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey, sislietfal.gov.tr.
- Department of Internal Medicine, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkey, akdeniz.edu.tr.
- Department of Endocrinology and Metabolism, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey, sislietfal.gov.tr.
- Department of Endocrinology and Metabolism, University of Health Sciences, Istanbul, Turkey, akdeniz.edu.tr.
ORCID-Profile: C Yarkutay Turkkan
Zitieren
APA
Yarkutay Turkkan, C., Canat, M. M., Erhan Gol, H., & Altuntas, Y. (2026). Blood Urea Nitrogen/Creatinine Ratio in Cushing’s Syndrome: Associations With Disease Status and Postoperative Changes. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/2517065
Vancouver
Yarkutay Turkkan C, Canat MM, Erhan Gol H, Altuntas Y. Blood Urea Nitrogen/Creatinine Ratio in Cushing’s Syndrome: Associations With Disease Status and Postoperative Changes. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/2517065
BibTeX
@article{YarkutayTurkkan2026,
author = {Yarkutay Turkkan, C and Canat, M M and Erhan Gol, H and Altuntas, Y},
title = {Blood Urea Nitrogen/Creatinine Ratio in Cushing’s Syndrome: Associations With Disease Status and Postoperative Changes},
journal = {International Journal of Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ije/2517065}
}
EUVIMED